Abstract: We show that DNAenzymes (deoxyribozymes) can introduce azide functional groups at tyrosine residues in peptide substrates.U sing in vitro selection, we identified deoxyribozymes that transfer the 2'-azido-2'-deoxyadenosine 5'-monophosphoryl group (2'-Az-dAMP) from the analogous 5'-triphosphate (2'-Az-dATP) onto the tyrosine hydroxyl group of ap eptide,w hich is either tethered to aD NA anchor or free.S ome of the new deoxyribozymes are general with regardt ot he amino acid residues surrounding the tyrosine, while other DNAe nzymes are sequence-selective.W euse one of the new deoxyribozymes to modify free peptide substrates by attaching PEG moieties and fluorescent labels.
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Synthesis of modified peptides and proteins is essential for understanding the functions of natural post-translational modifications,m onitoring protein distributions in vivo,m odulating therapeutic properties of peptides,p roteins,a ntibodies,and antibody-drug conjugates,and other applications. [1] In nature,t yrosine is modified via aw ide array of chemical changes. [2] Ty rosine has often been targeted for synthetic modification on the basis of its electron-rich nature and typically low abundance on protein surfaces.Approaches for tyrosine modification include reaction with electron-deficient diazonium salts, [3] three-component Mannich-type reaction with aldehydes and anilines, [4] alkylation with p-allylpalladium complexes, [5] reaction with preformed imines, [6] and aqueous ene-type reaction with PTAD derivatives. [7] Oxidative couplings have also been explored, [8] as have enzyme cascades. [9] However,t hese approaches each rely solely on differential physical accessibilities to discriminate among several tyrosines in the substrate.Some tyrosine modification reactions suffer from off-target reactivity of other electronrich residues such as tryptophan. [4c, 7, 8] Therefore,a lternative approaches are needed for sequence-selective tyrosine modification.
We pursued atwo-step approach to tyrosine modification using deoxyribozymes (DNAenzymes; Figure 1a ), which are particular DNAs equences that have catalytic activity. [10] In our approach, ad eoxyribozyme first catalyzes the reaction between the tyrosine side chain and 2'-azido-2'-deoxyadenosine 5'-triphosphate,or2'-Az-dATP,toform aphosphodiester bond (azido-adenylylation). Second, aparticular modification of interest is attached to the azido group by copper-catalyzed azide-alkyne cycloaddition (CuAAC) [1h,11] using an alkynefunctionalized reagent.
We initially performed in vitro selection [12] to establish viability of this approach, using the hexapeptide CAAYAA as the substrate (Figure 1b ). This hexapeptide was covalently attached via ad isulfide linkage and ah exa(ethylene glycol) [HEG] tether to aD NA anchor oligonucleotide,w hich was Figure 1 . Overview of DNA-catalyzed introduction of azide at tyrosine residues. a) Two-step peptide modificationb yDNA-catalyzed azidoadenylylation and CuAAC, with PEGylation as the specific example. b) Arrangement of initially random DNA pool (N 40 )and peptide substrate for in vitro selection of deoxyribozymes for azido-adenylylation. In each selection round, PAGE-shift capture of active DNA sequencesisachieved by CuAAC with PEG 5k -alkyne. See the Supporting Information,F igure S1 for nucleotide details of the selection process. The dashed loop enables selection but is dispensable for catalysis.
bound by Watson-Crick base pairs to one of the fixedsequence binding arms of the random N 40 DNAp ool. After exposure of the substrate-conjugated N 40 pool to 2'-Az-dATP, the catalytically active DNAs equences,w hich were now attached to an azido group,w ere increased in mass by CuAACwith alkyne-modified poly(ethylene glycol) that has an average molecular weight of 5000 (PEG 5k -alkyne). PEGylation is an important protein modification that increases renal clearance time,s uppresses aggregation, increases solubility,r educes immunogenicity and toxicity,a nd improves in vivo stability.
[13] Forc atalytically active DNAs equences, this "capture step"
[10i] attachment of PEG induces as ufficiently large polyacrylamide gel electrophoresis (PAGE) shift that enables the selection process.A fter PAGE separation, treatment with dithiothreitol (DTT) cleaved the disulfide bond, and another PAGE separation was performed. If the PEG-modified 2'-Az-dAMP group is attached not at the tyrosine residue but instead at some undesired position within the DNAi tself (for example,t he 5'-hydroxyl group or an ucleobase functional group), then disulfide cleavage will lead to only asmall PAGE shift, in comparison with the much larger PAGE shift upon removal of the entire PEG-modified hexapeptide.T his additional DTT/PAGEo peration proved necessary to avoid emergence of DNAs equences that catalyze undesired reactions (data not shown).
In each selection round, the incubation conditions included 100 mm 2'-Az-dATP in 70 mm HEPES,p H7.5, 1mm ZnCl 2 ,2 0mm MnCl 2 ,4 0mm MgCl 2 ,a nd 150 mm NaCl at 37 8 8Cf or 14 h( the divalent metal ions were included because each has proven useful in past DNAe nzyme selection experiments). After 8r ounds,t he azido-adenylylation activity of the pool reached 16 %( Supporting Information, Figure S2 a), and individual deoxyribozymes were cloned. As ingle sequence,n amed DzAz1 (Supporting Information, Figure S3 ), was identified. Partial randomization and reselection of DzAz1 (Supporting Information, Figure S2 b) revealed that the 5'-half sequence of the N 40 region could be varied extensively,w hereas the 3'-half sequence was highly conserved (Supporting Information, Figure S3 ). With the DNA-anchored CAAYAA substrate,t he reselected variant DzAz1b (11 mutations in the variable region) has 58 %s ingle-turnover azido-adenylylation yield with k obs of 0.38 AE 0.03 h À1 ,a nd variant DzAz1c (10 mutations) has 56 %y ield with k obs of 0.19 AE 0.03 h À1 ;p arent DzAz1 has 40 %yield with k obs of 0.79 AE 0.07 h À1 (each n = 3, AE sd;F igure 2). Product identity was validated by MALDI mass spectrometry (Supporting Information, is much more effective (Supporting Information, Figure S4 ). DzAz1 retains substantial activity when natural ATPi su sed in place of 2'-Az-dATP ( Figure 2 , k obs 0.3 h À1 for DzAz1 and both reselected variants), suggesting utility of this general approach for studying natural tyrosine adenylylation (AMPylation). [2, 14] With this proof-of-principle validation in hand, we sought to modify mixed-sequence peptides that have av ariety of amino acids near the tyrosine.I nt wo recent efforts with tyrosine-modifying deoxyribozymes,w ef ound that peptide sequence-selective catalysis by DNAc an be found from selection experiments in which mixed-sequence peptides are the substrates. [15] Here,f our new in vitro selection experiments were performed, each using one of four specific DNAanchored octapeptides CLQTYPRT, CQQPYITN, CERSYLMK,or CFQPYMQE.T he first sequence comprises amino acids 19-25 from the 32-mer salmon calcitonin (sCT), [16] and the remaining three sequences correspond, respectively,t oamino acids 15-21, 54-60 (with C56S) , and 78-84 of human interleukin-22 (146-mer hIL-22, amino acids 34-179 of the genomic sequence); [17] an artificial N-terminal cysteine was appended onto each peptide to allow disulfide linkage to the DNA anchor oligonucleotide.s CT is ah ormone prescribed for bone-related disorders such as osteoporosis,P agets disease, and hypercalcemia;h IL-22 is ac ytokine involved in proliferation, host defense,a nd the inflammatory response.E ach selection experiment was performed using the same incubation conditions as for the DNA-anchored CAAYAA.After 8-12 rounds,e ach selection experiment showed 16-44 %p ool azido-adenylylation activity ( Supporting Information, Figure S2 c-f) , and individual deoxyribozymes were cloned.
Five unique deoxyribozyme sequences designated DzAz2 through DzAz6 were identified from the selection experiment with the sCT-derived octapeptide CLQTYPRT,while the other three selections with the hIL-22 peptides each led to asingle DNAs equence,r espectively named DzAz7, DzAz8, and DzAz9 (Supporting Information, Figure S3 ). Thee ight new DNAe nzymes share no obvious sequence conservation among themselves or with DzAz1. DzAz2, DzAz7, and DzAz8 catalyze azido-adenylylation of their corresponding Figure 2 . Single-turnover kinetic assays of the DzAz1 deoxyribozyme, which was identified by in vitro selection using the DNA-anchored hexapeptide CAAYAA,a nd reselected variants DzAz1b and DzAz1c. Incubation conditions:7 0mm HEPES, pH 7.5, 1mm ZnCl 2 ,2 0mm MnCl 2 ,40mm MgCl 2 ,a nd 150 mm NaCl at 37 8 8Cwith 100 mm 2'-AzdATP or natural ATP. In the PAGE image, representative time points are shown for DzAz1b at t = 0, 2, and 24 h. S = substrate, P = product. See the SupportingInformation,F igure S3 for deoxyribozyme sequences, Table S2 for MALDI mass spectrometry,F igure S4 for assays of divalent metal ion dependence, and Figure S5 for assays with mixedsequence peptide substrates.
peptides in 61-87 %y ield in 24 hw ith k obs 0.1-0.5 h À1 (Figure 3a) ; the other deoxyribozymes have lower 9-27 %yields (Supporting Information, Figure S6a ). Natural ATPi sg enerally tolerated well in place of 2'-Az-dATP (Supporting Information, Figure S6 b ).
All nine of DzAz1 through DzAz9 were evaluated for azido-adenylylation activity with each of the four mixedsequence DNA-anchored peptides (Figure 3b ;S upporting Information, Figure S5 ). DzAz8 did not discriminate among any of the peptide sequences.I ns harp contrast, DzAz2 functioned well only with the CLQTYPRT substrate that was used during its identification. Theo ther seven deoxyribozymes each exhibited partial discrimination among the four peptide sequences,asexemplified by DzAz7.
Thep eptide sequence dependence of DzAz2 was evaluated in greater detail by testing its azido-adenylylation activity with systematic mutants of the DNA-anchored CLQTYPRT substrate.A se xpected, mutation of the Ty rt o either Phe or Ser abolished activity (Supporting Information, Figure S7 ). Thesix amino acids surrounding the Ty rwere then individually replaced with Ala, revealing that the required motif is YPR (Figure 4) . Introduction of this YPR motif into the other three peptide substrates enabled their azidoadenylylation by DzAz2 (Supporting Information, Figure S8 ), establishing YPR as both necessary and sufficient for DzAz2 reactivity.D zAz2 was also able to discriminate between two Ty rw ithin one longer peptide substrate on the basis of their sequence contexts ( Figure 5 ). In contrast, although the activity of the non-selective DzAz8 deoxyribozyme was also abolished upon mutating Ty rt oS er (as expected), all Ala mutations of CLQTYPRT were tolerated well (60-90 %y ield; Supporting Information, Figure S9 ).
Deoxyribozymes such as DzAz8 will be most useful if they can function with free peptide substrates that are not tethered to aD NA anchor oligonucleotide.A zido-adenylylation of untethered sCT was achieved by DzAz8 in 14 %yield in 24 h (Figure 6a ). In contrast, the sCT-specific DzAz2 did not function with untethered sCT (< 1%;d ata not shown). DzAz8 was also assayed with the 28-mer N-terminal fragment (C-terminal Tyr) of atrial natriuretic peptide (atriopeptin, ANP), which can induce natriuresis (sodium excretion in urine) and vasodilation and is commercialized in Japan for treatment of heart failure. [18] Azido-adenylylation of ANP by DzAz8 in 59 %y ield in 24 hw as observed (Figure 6a ). Both sCT and ANP were also adenylylated with natural ATP lacking the 2'-azido group,i nr espective yields of 6.7 %a nd 16 %( Supporting Information, Figure S10 ). TheH PLC- Figure 3 . Assays of the DzAz2 through DzAz9 deoxyribozymes, which were identified by in vitro selection using DNA-anchored octapeptides of mixed amino acid sequences. Incubation conditionsa sinFigure 2. a) Single-turnover kinetic assays with the particular peptide substrate used during identification of each deoxyribozyme. Data are shown for DzAz2, 7, and 8( k obs 0.14, 0.24, and 0.46 h À1 ). See the Supporting Information,F igure S6 afor data with the other deoxyribozymes. b) Assays with all four peptide sequences (yield at 24 h; each n = 3, AE sd);see Figure S5 for data with the other deoxyribozymes. Black bars denote the particular peptide substrate used during identification of that deoxyribozyme;gray bars are for the other peptide substrates. See the SupportingInformation,F igure S3 for deoxyribozyme sequences and Figure S6 bfor assays with natural ATPinplace of 2'-Az-dATP. purified azido-adenylylated sCT and ANP were further derivatized quantitatively via CuAACu sing either PEGalkyne or fluorescein-alkyne (Figure 6b) , with product validation by MALDI mass spectrometry (Supporting Information, Table S2 ).
In summary,wehave identified DNAenzymes for azidoadenylylation of tyrosine residues in peptide substrates.O ne such deoxyribozyme,D zAz2, is selective for the YPR sequence motif and is able to discriminate between tyrosine residues within as ingle peptide on the basis of sequence context. Another DNAenzyme,DzAz8, is peptide sequencegeneral, functions with free peptides,a nd allows their subsequent CuAACl abeling with moieties such as PEG and fluorescein. Finding peptide sequence selectivity by deoxyribozymes such as DzAz2 adds to the growing list of such observations that have now been made for three different DNA-catalyzed reactions, [15] establishing that DNAe nzymes have the broader ability to interact with side chains of peptide substrates.I no ngoing work, we are seeking to combine the key features of peptide sequence selectivity (for example, DzAz2) and reactivity with free peptide substrates (for example,D zAz8). We are also seeking to extend DNAcatalyzed reactivity from peptides to larger protein substrates. [19] Keywords: deoxyribozymes ·DNA ·invitro selection · peptide modification ·p eptides Figure 5 . DzAz2 differentiates between two Tyrinone peptide substrate. The LQTYPRT (site 1) and QQPYITN (site 2) sequence motifs (where DzAz2 is selective for the first motif;s ee Figure 3 ) were concatenated in either order within alonger peptide substrate via an arbitrary linker (ASK). The DNA-anchored peptide substrate was azidoadenylylated by DzAz2, and the product (as amixture of site 1a nd site 2m odifications) was PAGE-separated. In each case, DzAz2 preferentially modified LQTYPRT (site 1), as revealed by MALDI mass spectrometry after Lys-C cleavage to separate the two peptide segments and DTT treatment to remove the DNA anchor oligonucleotide. Each peptide product fragment is labeled Prod1 or Prod2 corresponding to site 1o rsite 2modification,a nd with asubscriptedLor R corresponding to the fragment location on the left or right side of the longer peptide before Lys-C cleavage. See the SupportingInformation, Table S2 for MS data and Supporting Information text for procedure and calculationo fdiscrimination factors from the mass spectrometry data. Figure 6 . Azido-adenylylation and subsequent PEG or fluorescein modification of untethered (free) peptide substrates by DzAz8. a) Azido-adenylylation by DzAz8 of sCT and ANP, assayed by HPLC (t = 24 h). b) Modification via CuAAC of azido-adenylylated sCT and ANP with PEG 5k -alkyne and fluorescein-alkyne, assayed by SDS-PAGE and imaging by Coomassie stain or fluorescence. un = unmodified substrate, Az = azido-adenylylated substrate, S = substrate, P = product, std = 2, 5, 10 kDa. Ascorbate is the reducing agent required for CuAAC. sCT (32 aa) CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP; ANP (28 aa) SLRRSSCFGGRMDRIGAQSGLGCNSFRY (disulfide bridge between the two C within both peptides).
